Redmond Cavan M. 4
4 · Oncocyte Corp · Filed Mar 16, 2022
Insider Transaction Report
Form 4
Redmond Cavan M.
Director
Transactions
- Purchase
Common Stock, no par value
2022-03-16$1.19/sh+40,000$47,560→ 110,863 total
4 · Oncocyte Corp · Filed Mar 16, 2022
Common Stock, no par value